Acute Lymphoblastic Leukemia (ALL) Disease(s) Brand Name … · 2020-03-05 · Acute Promyelocytic Leukemia VYXEOS Daunorubicin - Cytarabine Jazz Pharmaceutical Jump Start Program

Disease(s) Brand Name Drug Name Drug Company Phone Number Website

Asparlascalaspargase

pegol-mknl Servier

No financial assistance offered at this

time.

BESPONSA Ozogamicin Wyeth 1-877-744-5675https://www.pfizertogether.com/hcp/bes

ponsa/patient-financial-assistance

Blincyto Blinatumomab Amgen 1-855-669-9360

http://www.amgen.com/responsibility/ac

cess-to-medicine/reimbursement-

support-services-and-financial-

assistance-programs/

Kymriah Tisagenlecleucel Novartis 1-844-459-6742

https://www.hcp.novartis.com/products/

kymriah/acute-lymphoblastic-leukemia-

children/access/

Gleevec® Imatinib Mesylate Novartis 1-800-282-7630http://www.oncologyaccessnow.com/ind

ex.jsp

Gleevec® Generic Imatinib Mesylate Teva 1-844-546-8639 http://www.tevaimatinibsavings.com/

Generic Imatinib Imatinib Mesylate Sun Pharma 1/844-502-5950http://www.imatinibrx.com/home/patient-

assistance-program/

Iclusig® Ponatinib Takeda 1-844-817-6468https://www.takedaoncology1point.com/

patient/financial-assistance

Sprycel® DasatinibBristol-Myers

Squibb1-877-526-7334 https://www.sprycel.com/sprycel-assist

Trisenox Arsenic Trioxide Teva 1-877-237-4881 http://www.tevacares.org/

Acute

Lymphoblastic

Leukemia (ALL)

(Ph negative)

Blincyto Blinatumomab Amgen 1-855-669-9360





Disease(s) Brand Name Drug Name Drug Company Phone number Website

Dacogen DecitabineGood Days

Program 1-877-968-7233

http://www.needymeds.org/drug_list.taf

?_function=name&name=Dacogen

Idamycin Idarubicin Pfizer 1-866-706-2400http://www.pfizerrxpathways.com/?step

=1&step=1&step=1

IDHIFA Enasidenib Celgene 1-800-931-8691https://www.celgenepatientsupport.com/

enrollment/

Mylotarg Ozogamicin Pfizer 1-844-989-7284 www.pfizerrxpathways.com

Nivestym (a

biosimilar to

Neupogen)

filgrastim-aafi Pfizer 1-844-989-7284 www.pfizerrxpathways.com

RYDAPT Midostaurin Novartis 1-877-557-7756https://www.copay.novartisoncology.co

m

Venclexta VenetoclaxAbbvie/Genentec

h1-855-692-6729

https://www.genentech-

access.com/hcp/brands/venclexta.html

Co-Pay Assistance Resource Guide for Blood Cancer Patients

Acute

Lymphoblastic

Leukemia (ALL) -

B-cell Precursor

Ph+ Acute

Lymphoblastic

Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Acute Myeloid

Leukemia

Acute Lymphoblastic Leukemia (ALL)

Page 1 of 12

Daurismo Glasdegib Pfizer 877-744-5675https://www.pfizeroncologytogether.com

/


h1-855-692-6729



Acute Myeloid

Leukemia (AML)

CD33-Positive

Mylotarg Ozogamicin Pfizer 1-844-989-7284 www.pfizerrxpathways.com

AML Tx for blastic

plasmacytoid

dendritic cell

neoplasm (BPDCN)

in adult and

pediatric patients

two years and older

Elzonris tagraxofusp-erzs Stemline

Therapeutics1-833-478-3654 https://www.stemlinearc.com/

(t-AML) or AML with

Myelodysplasia-

related changes

(AML-MRC)

VYXEOSDaunorubicin -

Cytarabine

Jazz

Pharmaceutical

Jump Start

Program

1-855-589-9367 www.vyxeos.com

Acute Myeloid

Leukemia (AML)

with a susceptible

IDH1 mutation

Tibsovo ivosidenib

Agios

Pharmaceuticals,

Inc.

1-844-409-1141https://www.needymeds.org/papforms/

myaefe2609.pdf

Relapsed or

refractory Acute

Myeloid Leukemia

with an isocitrate

dehydrogenase-2

(IDH2) mutation

IDHIFA Enasidenib Celgene 1-800-931-8691https://www.celgenepatientsupport.com/

enrollment/

RYDAPT Midostaurin Novartis 1-877-557-7756https://www.copay.novartisoncology.co

m

XOSPATA gilteritinibAstellas Pharma

US 1-844-632-9272

https://www.astellaspharmasupportsolut

ions.com/products/xospata/patient_enro

llment_process.aspx


Acute Myeloid

Leukemia (AML) 75

yrs. and older or

Comorbidities (no

chemo option)

Relapsed or

refractory Acute

Myeloid Leukemia

(AML) with a FLT3

mutation

Acute Promyelocytic Leukemia

Page 2 of 12

Acute

Promyelocytic

Leukemia

VYXEOSDaunorubicin -

Cytarabine

Jazz

Pharmaceutical

Jump Start

Program

1-855-589-9367 www.vyxeos.com


Steroid-refractory

acute graft-versus-

host disease in

adult and pediactric

patients 12 years

and older

Jakafi® Ruxolitinib Incyte 1-855-452-5234https://www.incytecares.com/jakafi-

copay-assistance.aspx


Chronic Graft

Versus Host

Disease (cGVHD)

after failure of one

or more lines of

systemic therapy

ImbruvicaTM Ibrutinib

Pharmacyclics/

Janssen 1-877-877-3536

https://www.imbruvica.com/patient-

support/access-support


Arzerra Ofatumumab Novartis 1-800-282-7630http://www.oncologyaccessnow.com/ind

ex.jsp

COPIKTRA duvelisib Verastem 1-833-570-2273

http://www.verastem.com/wp-

content/uploads/2018/08/verastem-

cares-form.pdf

ImbruvicaTM IbrutinibPharmacuclics/J

anssen Biotech1-877-877-3536



Rituxan HycelaRituximab and

HyaluronidaseGenentech 1-888-249-4918


access.com/hcp/brands/rituxanhycela/fi

nd-patient-assistance.html


h1-855-692-6729




Chronic

Lymphocytic Arzerra Ofatumumab Novartis 1-800-282-7630

http://www.oncologyaccessnow.com/ind

ex.jsp

Chronic Lymphocytic Leukemia (CLL)

Chronic Graft Versus Host Disease (cGVHD)

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic

Lymphocytic

Leukemia

(CLL)/Small

Lymphocytic

Lymphoma (SLL)

Acute Graft Versus Host Disease (GvHD)

Page 3 of 12

BendekaBendamustine

HydrochlorideTeva 1-888-587-3263 http://bendeka.com/Support/assistance

Gazyva™ Obinutuzumab Genentech 1-888-249-4918http://www.genentech-

access.com/gazyva/patients


Pharmacyclics/

Janssen 1-877-877-3536



Rituxan® Rituximab Genentech 1-888-249-4918http://www.genentech-

access.com/rituxan-nhl-cll/patients






Treanda Bendamustine Teva 1-877-237-4881 http://www.tevacares.org/


h1-855-692-6729



Calquence acalabrutinibAstraZeneca

Pharmaceuticals 1-844-275-2360

https://www.calquence.com/patient/sup

port-for-patients/commercial-

insurance.html

Zydelig® Idelalisib Gilead1-844-6ACCESS

(1-844-622-2377)

http://www.zydeligaccessconnect.com/h

cp




cares-form.pdf


h1-855-692-6729



Previously

untreated chronic

lymphocytic

leukemia (CLL)


h1-855-692-6729




Chronic Myeloid

Leukemia (CML)Bosulif® Bosutinib Pfizer

1-855-4-BOSULIF

1-855-426-7854https://www.bosulif.com/bosulif-steps

Gleevec® Imatinib Mesylate Novartis 1-800-282-7630http://www.oncologyaccessnow.com/ind

ex.jsp


Gleevec® Generic Imatinib Mesylate Sun Pharma 1-844-502-5950http://www.imatinibrx.com/home/patient-

assistance-program/

Iclusig® Ponatinib Takeda 1-844-817-6468https://www.takedaoncology1point.com/

patient/financial-assistance

Synribo Omacetaxine Teva 1-877-237-4881 http://www.tevacares.org/

Sprycel® DasatinibBristol-Myers


Tasigna® Nilotinib Novartis 1-866-972-5244 www.CoPay.NovartisOncology.com

Chronic

Lymphocytic

Leukemia (CLL)

with 17p deletion

Chronic Myeloid Leukemia (CML)

Chronic

Lymphocytic

Leukemia (CLL)

Chronic Myeloid

Leukemia (CML)

Page 4 of 12

http://www.genentech-access.com/rituxan-nhl-cll/patients


https://www.calquence.com/patient/support-for-patients/commercial-insurance.html



https://www.bosulif.com/co-pay-card-eligibility-form

Newly-diagnosed

chronic phase (CP)

(Ph+)(CML)

Bosulif® Bosutinib Pfizer1-855-4-BOSULIF

1-855-426-7854https://www.bosulif.com/bosulif-steps

Chronic phase (CP)

(Ph+)(CML)Sprycel® Dasatinib

Bristol-Myers


PH+ CML chronic

phase/intolerant

prior to TKI

Tasigna® Nilotinib Novartis 1-866-972-5244 www.CoPay.NovartisOncology.com


Hairy Cell Leukemia LUMOXITI pasudotox-tdfk AstraZeneca


https://www.myaccess360.com/hcp/hcp-

branded-lumoxiti/support-

services/affordability-support.html


KEYTRUDA Pembrolizumab Merck & Co 1-855-257-3932https://www.merckaccessprogram-

keytruda.com/hcc/

Opdivo NivolumabBristol-Myers

Squibb1-800-861-0048

http://www.bmsaccesssupport.bmscust

omerconnect.com/opdivo/co-pay-

financial-assistance#

Adcetris®Brentuximab

vedotinSeattle Genetics

1-855-4SEAGEN

1-855-473-2436www.seagensecure.com

Opdivo NivolumabBristol-Myers

Squibb1-800-861-0048

http://www.bmsaccesssupport.bmscust

omerconnect.com/opdivo/co-pay-

financial-assistance#

Classical Hodgkin

lymphoma (cHL) at

high risk of relapse

or progression



1-855-4SEAGEN


Refractory Classical

Hodgkin Lymphoma

(cHL)


keytruda.com/hcc/

Erdheim-Chester

Disease (ECD) with

BRAF V600

Mutation

ZELBORAF vemurafenibHoffmann-La

Roche 1-866-422-2377


access.com/patient/brands/zelboraf/pati

ent-assistance-tool-page.html

Hodgkin Lymphoma

(HL)

Classical Hodgkin

lymphoma (cHL)

Hairy Cell Leukemia

Hodgkin lymphoma

Page 5 of 12

https://www.bosulif.com/co-pay-card-eligibility-form

http://www.seagensecure.com/


Hepatic Veno-

Occlusive Disease

(VOD) following

hematopoietic stem-

cell transplantation

(HSCT)

Defitelio defibrotide sodium Jazz

Pharmaceuticals1-888-837-4397

https://www.jazzpharma.com/responsibil

ity/patient-assistance/

Metastatic

Anaplastic

Lymphoma Kinase

(ALK)-positive non-

small cell lung

cancer (NSCLC)

ALUNBRIG Brigatinib Takeda/ARIAD 1-844-817-6488

https://www.pparx.org/prescription_assi

stance_programs/takeda_oncology_pati

ent_assistance_program

Metastatic Non-

Small Cell Lung

Cancer (NSCLC)

ZYKADIA Ceritinib Novartis 1-888-669-6682https://www.us.zykadia.com/patient-

support/financial-resources/




https://www.myaccess360.com/hcp/hcp-

branded-calquence/support-

services/affordability-support.html


Pharmacyclics/

Janssen 1-877-877-3536



Revlimid® Lenalidomide Celgene 1-800-931-8691https://www.celgenepatientsupport.com/

find-financial-help/

Mantle Cell

Lymphoma who

have received at

least 1 prior therapy

Brukinsa zanubrutinib BeiGene 1-877-828-5568No financial assistance offered at this

time.


Dacogen DecitabineGood Days

Program 1-877-968-7233

http://www.needymeds.org/drug_list.taf

?_function=name&name=Dacogen

Gleevec® Imatinib Mesylate Novartis 1-866-453-3832http://www.gleevec.com/patient/financial-

assistance.jsp


Gleevec® Generic Imatinib Mesylate Sun Pharma 1-844-502-5950http://www.imatinibrx.com/home/patient-

assistance-program/

Revlimid® Lenalidomide Celgene 1-800-931-8691http://www.velcade.com/paying-for-

treatment/

Vidaza Azacitidine Celgene 1-800-931-8691http://www.velcade.com/paying-for-

treatment/

Mantle Cell Lymphoma (MCL)

Mantle Cell

Lymphoma (MCL)

Myelodysplastic Syndromes (MDS)

Myelodysplastic

Syndromes (MDS)

Myelodysplastic

Syndromes (MDS)

Page 6 of 12


Myelofibrosis Jakafi® Ruxolitinib Incyte1-855-4-JAKAFI

1-855-452-5234

http://www.jakafi.com/IncyteCARES/co-

pay-assistance

Intermediate- 2 or

High Risk Primary

or Secondary (post-

polycythemia vera

or post-essential

thrombocythemia)

Myelofibrosis (MF)

Inrebic ® Fedratinib Celgene1-800-931-8691

EXT 4080

https://celgenepatientsupport.com/inrebi

c-patient


Darzalex Daratumumab Janssen 1-844-553-2792http://www.janssenaccessone.com/pag

es/darzalex/patientassist/intro.jsp

Doxil DoxorubicinJohnson &

Johnson1-800-652-6227

http://www.goodrx.com/doxil/savings-

tips

Empliciti ElotuzumabBristol-Myers

Squibb1-800-861-0048 http://www.empliciti.com/access

Farydak® Panobinostat Novartis 1-800-282-7630http://www.oncologyaccessnow.com/ind

ex.jsp


Pharmacyclics/

Janssen 1-877-877-3536



Istodax® Romidepsin Celgene 1-800-931-8691 http://www.celgenepatientsupport.com/

Kyprolis™ Carfilzomib Amgen 1-888-427-7478





Ninlaro Ixazomib Takeda 1-844-617-6468 http://www.ninlaro.com/1point

Pomalyst® Pomalidomide Celgene 1-800-931-8691https://www.celgenepatientsupport.com/




Thalomid® Thalidomide Celgene 1-800-931-8691https://www.celgenepatientsupport.com/


Velcade Bortezomib Takeda 1-866-835-2233http://www.velcade.com/paying-for-

treatment/





Ninlaro Ixazomib

Millennium

Pharmaceuticals/

Takeda

1-844-617-6468 http://www.ninlaro.com/1point

Myeloma

Myeloma

Myelofibrosis

Myeloma

Multiple Myeloma

who have received

at least one prior

therapy

Page 7 of 12

http://www.jakafi.com/IncyteCARES/co-pay-assistance

http://www.jakafi.com/IncyteCARES/co-pay-assistance

http://www.celgenepatientsupport.com/

Multiple Myeloma

who have received

at least two prior

regimens

Farydak® Panobinostat Novartis 1-800-282-7630http://www.oncologyaccessnow.com/ind

ex.jsp

Mulitple Myeloma who

have received at least

two prior therapies

including lenalidomide

and proteasome inhibitor*In combination with

pomalidomide and

dexamethasone

Sarclisa® Isatuximab-irfc Sanofi 1-833-930-2273 SanofiCareAssist.com/Sarclisa



Empliciti ElotuzumabBristol-Myers

Squibb1-800-861-0048 http://www.empliciti.com/access

Multiple Myeloma

newly diagnosed

adult patients who

are ineligible for

autologus stem cell

transplant in

combination with

lenalidomide and

dexamethasone



Multiple Myeloma

newly diagnosed

adult patients who

are eligible for

autologous stem cell

transplant in

combination with

bortezomib,

thalidomide, and

dexamethasone



Relapsed or

refractory multiple

myeloma who have

received at least

one prior therapy in

combination with

lenalidomide and

dexamethasone



Relapsed Multiple

Myeloma who have

received one to

three prior lines of

therapy

Kyprolis™ Carfilzomib Amgen 1-888-427-7478





Multiple Myeloma

who have received

one to three prior

therapies

Page 8 of 12

Relapsed or

Refractory Multiple

Myeloma (RRMM) who have received at least

four prior therapies and

whose disease is refractory to

at least two proteasome

inhibitors, at least two

immunomodulatory agents,

and an anti-CD38 monoclonal

antibody

Xpovio™ selinexorKaryopharm

Therapeutics Inc

No financial assistance offered at this

time.


for adult pts w/

relapsed or

refractory (MF) or

(SS) after at least

one prior systemic

therapy

Poteligeomogamulizumab-

kpkc Kyowa Kirin 1-833-552-2737

https://www.poteligeohcp.com/support/c

opay-program.html


Fulphila (a

biosimilar to

Neulasta)

pegfilgrastim-jmdb Mylan GmbH 1-833-695-2623https://www.mylanadvocateportal.com/

myl/login#/

Nivestym (a

biosimilar to

Neupogen)

filgrastim-aafi Pfizer844-989-PATH

(7284)

https://www.pfizerencompassresources.co

m/sites/default/files/pen-

pfizer_patient_assistance_program_applic

ation_for-pfizer_encompass_patients.pdf

Retacrit epoetin alfa-epbx Hospira Inc 1-844-722-6672https://www.pfizerpro.com/product/retac

rit/hcp

Neutropenia

ZARVIO

(biosimilar for

Neupogen,

approved for same

use)

Filgrastim-sndz Sandoz 1-844-726-3691 http://www.zarxio.com/patient/support/



VedotinSeattle Genetics

1-855-4SEAGEN


BendekaBendamustine

HydrochlorideTeva 1-888-587-3263 http://bendeka.com/Support/assistance

Rituxan® Rituximab Genentech 1-888-249-4918http://www.genentech-

access.com/rituxan-nhl-cll/patients

Treanda Bendamustine Teva 1-877-237-4881 http://www.tevacares.org/

Zydelig Idelaisib Gilead 1-844-622-2377

http://www.zydeligaccessconnect.com/p

atient/affording-zydelig/patient-

assistance-program

BPDCN in adults or

pediatric patients 2

years or older

Elzonris Tagraxofusp-erzs Stemline

Therapeutics1-833-478-3654 https://www.stemlinearc.com/

Neutropenia

Mycosis fungoides (MF) or Sézary syndrome (SS)

Neutropenia

Non-Hodgkin’s Lymphoma (all Subtypes)

Non-Hodgkin

Lymphoma (NHL)

Page 9 of 12




https://www.stemlinearc.com/

Peripheral T-cell

LymphomaIstodax Romidepsin Celgene

1-800-931-8691

ext 4093

https://www.celgenepatientsupport.com/


Previously

untreated systemic

anaplastic large cell

lymphoma or other

CD30-expressing

peripheral T-cell

lymphomas



1-855-4SEAGEN


ALUNBRIG Brigatinib Takeda/ARIAD 1-844-817-6488

https://www.pparx.org/prescription_assi

stance_programs/takeda_oncology_pati

ent_assistance_program

ZYKADIA Ceritinib Novartis 1-888-669-6682https://www.us.zykadia.com/patient-

support/financial-resources/

CD20-positive, B-

cell non-Hodgkin’s

lymphoma (NHL)

Truxima rituximab-abbs Celltrion/Teva 1-877-237-4881 http://www.tevacares.org/

Poteligeomogamulizumab-

kpkc Kyowa Kirin 1-833-552-2737

https://www.poteligeohcp.com/support/c

opay-program.html

Istodax Romidepsin Celgene1-800-931-8691

ext 4093

https://www.celgenepatientsupport.com/


ALIQOPA Copanlisib Bayer 1-833-254-7672

https://www.hcp.aliqopa-us.com/access-

and-reimbursement/patient-and-

financial-support/

Kymriah Tisagenlecleucel Novartis 1-844-459-6742

https://www.hcp.novartis.com/products/

kymriah/acute-lymphoblastic-leukemia-

children/access/






Diffuse large B-cell

lymphoma (DLBCL) YESCARTA

axicabtagene

ciloleucel Kite Pharma 1-844-454-5483 https://www.yescarta.com/support

Relapsed or

refractory diffuse

large B-cell

lymphoma after at

least two prior

therapies

Polivypolatuzumab

vedotin-piiqGenentech 866-422-2377


access.com/hcp/brands/polivy/find-

patient-assistance/help-for-uninsured-

patients.html

Previously treated

marginal zone

lymphoma (MZL) in

combination with a

rituximab product

Revlimid® lenalidomide Celgene 1-800-931-8691

https://www.revlimid.com/mm-

patient/affording-revlimid/financial-

assistance/?mm-self-id=yes

ALIQOPA Copanlisib Bayer 1-833-254-7672

https://www.hcp.aliqopa-us.com/access-

and-reimbursement/patient-and-

financial-support/




cares-form.pdf

Gazyva™ Obinutuzumab Genentech 1-888-249-4918http://www.genentech-


Diffuse large B-cell

lymphoma (DLBCL)

Follicular

Lymphoma

Anaplastic

Lymphoma Kinase

Cutaneous T-Cell

Lymphoma

Page 10 of 12


Gazyva Injection Obinutuzumab Genentech 1-888-249-4918http://www.genentech-








(1-844-622-2377)


cp

Previously treated

follicular lymphoma

(FL) in combination

with a rituximab

product

Revlimid® lenalidomide Celgene 1-800-931-8691

https://www.revlimid.com/mm-

patient/affording-revlimid/financial-

assistance/?mm-self-id=yes


(pcALCL) or CD30-

expressing mycosis

fungoides (MF) who

have received prior

systemic therapy



1-855-4SEAGEN



(PMBCL), or pts

who have relapsed

after two or more

prior lines of

therapy


keytruda.com/hcc/



(1-844-622-2377)


cp



https://www.calquence.com/patient/sup

port-for-patients/commercial-

insurance.html


h1-855-692-6729



Previously

untreated small

lymphocytic

lymphoma (SLL)


h1-855-692-6729




Thrombocytopenia TAVALISSE

fostamatinib

disodium

hexahydrate

tablets

Rigel

Pharmaceuticals1-833-744-3562 https://tavalisse.com/


Thrombocytopenia

Waldenstrom’s Macroglobulinemia (WM)

Follicular

Lymphoma

Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL)

Refractory Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Small Lymphocytic Leukemia (SLL)

Small Lymphocytic

Leukemia (SLL)

Page 11 of 12





Waldenstrom’s

macroglobulinemia

(WM)Imbruvica

TM IbrutinibPharmacyclics/

Janssen 1-877-877-3536




DefitelioDefibrotide

Sodium

Jazz

Pharmaceuticals1-888-837-4397

https://www.jazzpharma.com/responsibil

ity/patient-assistance/

Granix Tbo-Filgrastim Teva 1-888-587-3263http://www.granixhcp.com/Support/GRA

NIX-CORE.aspx

Idamycin Idarubicin Pfizer 1-844-989-7284 http://www.pfizerrxpathways.com/

Neulasta® (G-

CSF) Pegfilgrastim Amgen

1-888-4ASSIST

1-888-427-7478





Neupogen® (G-

CSF)Filgrastim Amgen

1-888-4ASSIST

1-888-427-7478





ZARVIO

(biosimilar for

Neupogen,

approved for same

use)

Filgrastim-sndz Sandoz 1-844-726-3691 http://www.zarxio.com/patient/support/

Procrit Epoetin Alfa Janssen 1-877-227-3728http://www.janssenprescriptionassistanc

e.com/procrit-cost-assistance

Granix TBO-Filgrastim Teva Core 1-888-587-3263

http://www.granixrx.com/Staying-

supported/GRANIX-financial-

assistance.aspx

All Blood Cancers

All Blood Cancers

All Blood Cancers

Page 12 of 12

Documents

Acute Lymphoblastic Leukemia (ALL) Disease(s) Brand Name … · 2020-03-05 · Acute Promyelocytic Leukemia VYXEOS Daunorubicin - Cytarabine Jazz Pharmaceutical Jump Start Program